Cost-Effectiveness Analysis of Ranibizumab
Ranibizumab cost-effectiveness analysis compared to intravitreal implantation of dexamethasone, triamcinolone, aflibercept and bevacizumab, for patients in the treatment of patients with macular edema secondary to central retinal vein occlusion in Colombia.
*Available in Spanish Only*
IETS. Colombia.
Report Nº 148.